Yoshihisa Tokumaru

Roswell Park Comprehensive Cancer Center

Also affiliated with Gifu University Hospital, Saitama International Medical Center, Gifu University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.359Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Association of allograft rejection response score with biological cancer aggressiveness and with better survival in triple-negative breast cancer (TNBC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.561

Top 49%

0.359DataRank

Top 49%5 citations

Lan Le, Fernando A. Angarita, Yoshihisa Tokumaru, Li Yan, Ryusei Matsuyama +3 more

Papers

Driven by 37 papers — median percentile 51. Top paper: “M1 Macrophage and M1/M2 ratio defined by transcriptomic signatures resemble only part of their conventional clinical characteristics in breast cancer”.

M1 Macrophage and M1/M2 ratio defined by transcriptomic signatures resemble only part of their conventional clinical characteristics in breast cancer

Scientific Reports(2020)10.1038/s41598-020-73624-w

N/A

0.807DataRank · unranked

216 citations

Yoshihisa Tokumaru, Mariko Asaoka, Li Yan, Vikas Satyananda, Ryusei Matsuyama +7 more

The E2F Pathway Score as a Predictive Biomarker of Response to Neoadjuvant Therapy in ER+/HER2− Breast Cancer

Cells(2020)10.3390/cells9071643

N/A

0.737DataRank · unranked

135 citations

Hideo Takahashi, Yoshihisa Tokumaru, Li Yan, Omar M. Rashid, Masayuki Nagahashi +4 more

Intra-Tumoral Angiogenesis Is Associated with Inflammation, Immune Reaction and Metastatic Recurrence in Breast Cancer

International Journal of Molecular Sciences(2020)10.3390/ijms21186708

N/A

0.680DataRank · unranked

92 citations

Stephanie Newman, Yoshihisa Tokumaru, Li Yan, Ryusei Matsuyama, Itaru Endo +3 more

Degree of Early Estrogen Response Predict Survival after Endocrine Therapy in Primary and Metastatic ER-Positive Breast Cancer

Cancers(2020)10.3390/cancers12123557

N/A

0.606DataRank · unranked

56 citations

Yoshihisa Tokumaru, Fernando A. Angarita, Li Yan, Ryusei Matsuyama, Itaru Endo +2 more

Adipogenesis in triple-negative breast cancer is associated with unfavorable tumor immune microenvironment and with worse survival

Scientific Reports(2021)10.1038/s41598-021-91897-7

N/A

0.601DataRank · unranked

54 citations

Yoshihisa Tokumaru, Fernando A. Angarita, Lan Lee, Li Yan, Ryusei Matsuyama +3 more

Enhanced immune response outperform aggressive cancer biology and is associated with better survival in triple-negative breast cancer

npj Breast Cancer(2022)10.1038/s41523-022-00466-2

N/A

0.571DataRank · unranked

44 citations

Ankit Patel, Rongrong Wu, Lan Le, Yoshihisa Tokumaru, Akimitsu Yamada +6 more

Abundance of Microvascular Endothelial Cells Is Associated with Response to Chemotherapy and Prognosis in Colorectal Cancer

Cancers(2021)10.3390/cancers13061477

N/A

0.520DataRank · unranked

31 citations

Michelle R. Huyser, Lan Le, Yoshihisa Tokumaru, Li Yan, Ryusei Matsuyama +3 more

A Novel Four-Gene Score to Predict Pathologically Complete (R0) Resection and Survival in Pancreatic Cancer

Cancers(2020)10.3390/cancers12123635

N/A

0.515DataRank · unranked

30 citations

Yoshihisa Tokumaru, Ankit Patel, Li Yan, Ryusei Matsuyama, Itaru Endo +3 more

Options to Determine Pathological Response of Axillary Lymph Node Metastasis after Neoadjuvant Chemotherapy in Advanced Breast Cancer

Cancers(2021)10.3390/cancers13164167

N/A

0.385DataRank · unranked

12 citations

Jessica Young, Yoshihisa Tokumaru, Marie Quinn, Stephen B. Edge, Kazuaki Takabe +1 more

Association of allograft rejection response score with biological cancer aggressiveness and with better survival in triple-negative breast cancer (TNBC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.561

Top 49%

0.359DataRank

Top 49%5 citations

Lan Le, Fernando A. Angarita, Yoshihisa Tokumaru, Li Yan, Ryusei Matsuyama +3 more

The clinical relevance of unfolded protein response signaling in breast cancer

Research Square(2022)10.21203/rs.3.rs-1480002/v1

N/A

0.345DataRank · unranked

9 citations

Arya Mariam Roy, Shipra Gandhi, Yoshihisa Tokumaru, Li Yan, Akimitsu Yamada +3 more

Should we target “intermediate expression” of HER2 in older estrogen receptor positive patients?

Translational Cancer Research(2020)10.21037/tcr-20-2231

N/A

0.165DataRank · unranked

2 citations

Lan Le, Mariko Asaoka, Manabu Futamura, Takashi Ishikawa, Kazuhiro Yoshida +2 more

Urine as a Source of Liquid Biopsy for Cancer

Cancers(2021)10.3390/cancers13112652

N/A

0DataRank · unranked

128 citations

Vijayashree Murthy, Hideo Takahashi, Michelle R. Huyser, Maiko Okano, Yoshihisa Tokumaru +5 more

Enhanced DNA Repair Pathway is Associated with Cell Proliferation and Worse Survival in Hepatocellular Carcinoma (HCC)

Cancers(2021)10.3390/cancers13020323

N/A

0DataRank · unranked

59 citations

Tae Hee Kim, Yoshihisa Tokumaru, Li Yan, Ryusei Matsuyama, Itaru Endo +3 more

Annexin A1 Expression Is Associated with Epithelial–Mesenchymal Transition (EMT), Cell Proliferation, Prognosis, and Drug Response in Pancreatic Cancer

Cells(2021)10.3390/cells10030653

N/A

0DataRank · unranked

53 citations

Yoshihisa Tokumaru, Swagoto Mukhopadhyay, Li Yan, Ryusei Matsuyama, Itaru Endo +2 more

Low expression of miR-29a is associated with aggressive biology and worse survival in gastric cancer

Scientific Reports(2021)10.1038/s41598-021-93681-z

N/A

0DataRank · unranked

22 citations

Masanori Oshi, Michelle R. Huyser, Li Yan, Masahiro Fukada, Nobuhisa Matsuhashi +5 more

Low expression of microRNA-195 is a poor prognostic marker for ER-positive breast cancer patients.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e12576

N/A

0DataRank · unranked

2 citations

Masanori Oshi, Eriko Katsuta, Vijayashree Murthy, Nobuhisa Matsuhashi, Manabu Futamura +3 more

Can Intratumoral neutrophil lymphocyte ratio (NLR) be a prognostic biomarker in breast cancer patients?

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e12573

N/A

0DataRank · unranked

2 citations

Masanori Oshi, Vijayashree Murthy, Eriko Katsuta, Nobuhisa Matsuhashi, Manabu Futamura +3 more

G2M checkpoint signaling among six-cell proliferation-related pathway as a biomarker for prediction and prognosis in pancreatic cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e16264

N/A

0DataRank · unranked

1 citations

Lan Le, Yoshihisa Tokumaru, Li Yan, Ryusei Matsuyama, Itaru Endo +2 more

Abundance of reactive oxygen species (ROS) is associated with tumor aggressiveness, immune response, and worse survival in breast cancer

Breast Cancer Research and Treatment(2022)10.1007/s10549-022-06633-0

N/A

0DataRank · unranked

77 citations

Shipra Gandhi, Li Yan, Yoshihisa Tokumaru, Rongrong Wu, Akimitsu Yamada +4 more

NR2F1, a Tumor Dormancy Marker, Is Expressed Predominantly in Cancer-Associated Fibroblasts and Is Associated with Suppressed Breast Cancer Cell Proliferation

Cancers(2022)10.3390/cancers14122962

N/A

0DataRank · unranked

39 citations

Arya Mariam Roy, Yoshihisa Tokumaru, Shipra Gandhi, Mariko Asaoka, Masanori Oshi +4 more

The Role of the Microbiome on the Pathogenesis and Treatment of Colorectal Cancer

Cancers(2022)10.3390/cancers14225685

N/A

0DataRank · unranked

28 citations

Rongrong Wu, Yoshihisa Tokumaru, Krista P. Terracina, Kazuaki Takabe, Irene Yu

Clinical Relevance of Estrogen Reactivity in the Breast Cancer Microenvironment

Frontiers in Oncology(2022)10.3389/fonc.2022.865024

N/A

0DataRank · unranked

20 citations

Yoshihisa Tokumaru, Masanori Oshi, Rongrong Wu, Ankit Patel, Wanqing Tian +5 more

High miR-99b expression is associated with cell proliferation and worse patient outcomes in breast cancer

Research Square(2022)10.21203/rs.3.rs-1963644/v1

N/A

0DataRank · unranked

13 citations

Yoshihisa Tokumaru, Matthew G.K. Benesch, Nobuhiko Sugito, Rongrong Wu, Li Yan +6 more

miR-150 expression in breast cancer attracts and activates immune cells, and is associated with better patient outcome.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.570

N/A

0DataRank · unranked

3 citations

Aparna Maiti, Rongrong Wu, Yoshihisa Tokumaru, Vijayashree Murthy, Li Yan +5 more

Association of NR2F1, a tumor dormancy marker, with cancer cell proliferation and lymph node metastasis, and expression in cancer-associated fibroblasts in breast cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e12550

N/A

0DataRank · unranked

3 citations

Masanori Oshi, Mariko Asaoka, Yoshihisa Tokumaru, Takashi Ishikawa, Kazuaki Takabe +1 more

G2M Cell Cycle Pathway Score as a Prognostic Biomarker of Metastasis in Estrogen Receptor (ER)-Positive Breast Cancer

International Journal of Molecular Sciences(2020)10.3390/ijms21082921

N/A

0DataRank · unranked

165 citations

Hideo Takahashi, Yoshihisa Tokumaru, Li Yan, Omar M. Rashid, Ryusei Matsuyama +3 more

CD8 T Cell Score as a Prognostic Biomarker for Triple Negative Breast Cancer

International Journal of Molecular Sciences(2020)10.3390/ijms21186968

N/A

0DataRank · unranked

217 citations

Mariko Asaoka, Yoshihisa Tokumaru, Li Yan, Ryusei Matsuyama, Takashi Ishikawa +3 more

Abundance of Regulatory T Cell (Treg) as a Predictive Biomarker for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

Cancers(2020)10.3390/cancers12103038

N/A

0DataRank · unranked

106 citations

Mariko Asaoka, Yoshihisa Tokumaru, Fernando A. Angarita, Li Yan, Ryusei Matsuyama +5 more

Plasmacytoid Dendritic Cell (pDC) Infiltration Correlate with Tumor Infiltrating Lymphocytes, Cancer Immunity, and Better Survival in Triple Negative Breast Cancer (TNBC) More Strongly than Conventional Dendritic Cell (cDC)

Cancers(2020)10.3390/cancers12113342

N/A

0DataRank · unranked

101 citations

Stephanie Newman, Yoshihisa Tokumaru, Li Yan, Ryusei Matsuyama, Paweł Kaliński +3 more

Inflammation Is Associated with Worse Outcome in the Whole Cohort but with Better Outcome in Triple‐Negative Subtype of Breast Cancer Patients

Journal of Immunology Research(2020)10.1155/2020/5618786

N/A

0DataRank · unranked

69 citations

Stephanie Newman, Yoshihisa Tokumaru, Li Yan, Ryusei Matsuyama, Itaru Endo +2 more

Intratumoral Adipocyte-High Breast Cancer Enrich for Metastatic and Inflammation-Related Pathways but Associated with Less Cancer Cell Proliferation

International Journal of Molecular Sciences(2020)10.3390/ijms21165744

N/A

0DataRank · unranked

56 citations

Masanori Oshi, Eriko Katsuta, Li Yan, Jing Huang, Masayuki Nagahashi +5 more

ITPKC as a Prognostic and Predictive Biomarker of Neoadjuvant Chemotherapy for Triple Negative Breast Cancer

Cancers(2020)10.3390/cancers12102758

N/A

0DataRank · unranked

46 citations

Stephanie Newman, Vijayashree Murthy, Yoshihisa Tokumaru, Li Yan, Ryusei Matsuyama +3 more

High Expression of NRF2 Is Associated with Increased Tumor-Infiltrating Lymphocytes and Cancer Immunity in ER-Positive/HER2-Negative Breast Cancer

Cancers(2020)10.3390/cancers12123856

N/A

0DataRank · unranked

42 citations

Fernando A. Angarita, Yoshihisa Tokumaru, Li Yan, Ryusei Matsuyama, Itaru Endo +2 more

High G2M Pathway Score Pancreatic Cancer is Associated with Worse Survival, Particularly after Margin-Positive (R1 or R2) Resection

Cancers(2020)10.3390/cancers12102871

N/A

0DataRank · unranked

63 citations

Stephanie Newman, Yoshihisa Tokumaru, Li Yan, Ryusei Matsuyama, Itaru Endo +3 more

Transcriptomic Profile of Lymphovascular Invasion, a Known Risk Factor of Pancreatic Ductal Adenocarcinoma Metastasis

Cancers(2020)10.3390/cancers12082033

N/A

0DataRank · unranked

39 citations

Eriko Katsuta, Li Yan, Yoshihisa Tokumaru, Matthew H. G. Katz, Kazuaki Takabe +1 more

Prevalence and clinical relevance of tumor-associated tissue eosinophilia (TATE) in breast cancer

Surgery(2020)10.1016/j.surg.2020.07.052

N/A

0DataRank · unranked

24 citations

Yoshihisa Tokumaru, Mariko Asaoka, Masanori Oshi, Kristopher Attwood, Kazuhiro Yoshida +3 more

Yoshihisa Tokumaru

Indexed papers

Top data-sharing exemplar

Papers